Group items tagged

Piramal Pharma Solutions, which is the contract development and manufacturing company of Piramal Enterprises, has acquired a solid oral dosage drug manufacturing facility of US-based G&W Laboratories for around $17.5 million.

Piramal Enterprises has a history of making over 50 acquisitions. The company is known for its efficient capital allocation. Both PEL and PPL have same the promoter group. Piramal Enterprises holds 17.53% stake in PPL which will get cancelled post-merger

Piramal Healthcare Friday said it will sell its healthcare solutions business in India, Sri Lanka and Nepal to US-based Abbott for $3.72 billion.

Abbott (NYSE: ABT) announced a definitive agreement with Piramal Healthcare Limited to acquire full ownership of Piramal's Healthcare Solutions business (Domestic Formulations), a leader in the Indian branded generics market, for an up-front payment of $2.12 billion, plus $400 million annually for the next four years, giving Abbott the No. 1 position in the Indian pharmaceutical market.

The report titled "Sterile Vials Market: Opportunity Analysis and Future Assessment 2022-2030" freshly published by Reports & Insights has the primary objective to offer its clients outright in-depth and meticulous information about the respective market along with the thorough knowledge of the statistics oriented in the direction of development of the respective market. For a clearer picture of the readers, the report also offers comprehensive know-how of the market, conceptual structure, and prevailing trends of the market together with the detailed textual and graphical representation. In addition, the report also cites comprehensively about the key players competing in the market for the unfluctuating intrigue of its readers. Request a Sample Copy of this Report @: https://reportsandinsights.com/sample-request/7524 Reports & Insights Overview The non-identical approach of Reports and Insights stands with conceptual methods backed up with the data analysis. The novel market understanding approach makes up the standard of the assessment results that give better opportunity for the customers to put their effort. A research report on the Sterile Vials market by Reports and Insights is an in-depth and extensive study of the market based on the necessary data crunching and statistical analysis. It provides a brief view of the dynamics flowing through the market, which includes the factors that supports market and the factors that are acting as impedance for the growth of the market. Furthermore, the report includes the various trends and opportunities in the respective market in different regions for a better understanding of readers that helps to analyze the potential of the market. Wish to Know More About the Study? Click here to get a Report Description: https://reportsandinsights.com/report/sterile-vials-market Sterile Vials Market Segmentation The sterile vials market is segmented on the basis of product, volume, material, end user, and region. By Pro

The report is titled as 'General Anesthesia Drugs Market: Opportunity Analysis and Future Assessment 2022-2030'. An overview of conceptual frameworks, analytical approaches of the General Anesthesia Drugs market is the main objective of the report, which further consists the market opportunity and insights of the data involved in the making of the respective market.

The report is titled as 'Pharmaceutical Packaging Market: Opportunity Analysis and Future Assessment 2022-2030'. An overview of conceptual frameworks, analytical approaches of the Pharmaceutical Packaging market is the main objective of the report, which further consists the market opportunity and insights of the data involved in the making of the respective market.